Home

Syncom Formulations (india) Ltd EPS

Image

Syncom Formulations (India) Ltd

NSE: SYNCOMFORMUL

EPS

₹ 0.42

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Syncom Formulations (India) Ltd is ₹ 0.42 as of 21 Feb 25 .
  • The earning per share of Syncom Formulations (India) Ltd changed from ₹ 0.07 to ₹ 0.14 over 7 quarters. This represents a CAGR of 48.60% .

Historical Earning per Share of Syncom Formulations (India) Ltd

No data available

* All values are in

Company Fundamentals for Syncom Formulations (India) Ltd

Market Cap

1,598 Cr

EPS

0.4

P/E Ratio (TTM)

40.5

P/B Ratio (TTM)

5.1

Day’s High

17.7

Day’s Low

16.96

DTE

0.0

ROE

10.6

52 Week High

27.94

52 Week Low

11.0

ROCE

14.3

Market Price of Syncom Formulations (India) Ltd

1M

1Y

3Y

5Y

Monitoring Syncom Formulations (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202517
20 Feb 202517.33
19 Feb 202517.01
18 Feb 202516.67
17 Feb 202517.16
14 Feb 202517.57
13 Feb 202518.04
12 Feb 202518.06
11 Feb 202518.34
10 Feb 202518.01

SWOT Analysis Of Syncom Formulations (India) Ltd

Strength

3

che

Weakness

3

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Syncom Formulations (India) Ltd

Asset Value vs Market Value of Syncom Formulations (India) Ltd

Market Value

1,598

Asset Value

Value addition

6.5 X

212

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Syncom Formulations (India) Ltd1598
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical Revenue of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Syncom Formulations (India) Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Syncom Formulations (India) Ltd News Hub

Nifty slips below 24,200 level; Nifty bank shares buck trend; HDFC Bank drops 2.93%

The main equity indices traded with significant losses in mid-afternoon trade. The Nifty dropped bel

Read more

13 Aug 24

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total expenditure

Read more

13 Aug 24

Syncom Formulations (India) consolidated net profit rises 73.41% in the June 2024 quarter

Net profit of Syncom Formulations (India) rose 73.41% to Rs 7.63 crore in the quarter ended June 202

Read more

12 Aug 24

Syncom Formulations (India) announces board meeting date

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 Augus

Read more

06 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Syncom Formulations (India) Ltd

What is the EPS of Syncom Formulations (India) Ltd stock?

The Earnings Per Share (EPS) of Syncom Formulations (India) Ltd is 0.42. An EPS is the amount of net income attributed to each share of a common stock.

How is Syncom Formulations (India) Ltd EPS calculated?

The EPS of Syncom Formulations (India) Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Syncom Formulations (India) Ltd report its EPS?

Syncom Formulations (India) Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Syncom Formulations (India) Ltd EPS?

Factors that influence the EPS of Syncom Formulations (India) Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Syncom Formulations (India) Ltd EPS growth indicate future performance?

Yes, consistent growth in Syncom Formulations (India) Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions